← Eichor
Study identifier: NCT05672706 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of Pressure Waveform Analysis in Coronary Artery-II

Condition: Ischemic Heart Disease  ·  Sponsor: National Taiwan University Hospital Hsin-Chu Branch

PhaseN/A
Planned participants30
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to test the feasibility of intracoronary adenosine administration during coronary flow reserve(CFR) and index of microcirculatory resistance(IMR) assessment in a population with angina. The main questions it aims to answer are: * Repeatability of CFR and IMR assessment while hyperemia with intracoronary adenosine was administered. * Evaluate the correlation of the intrinsic signal of coronary waveform versus physiologic ischemia, while defined by fractional flow reserve(FFR) and CFR respectively. * The predictive value of FFR, CFR, and IMR on major adverse cardiovascular outcomes in 3 years Participants will undergo FFR, CFR, and IMR assessments in the catheterization laboratory of the National Taiwan University Hospital Hsin-Chu Branch, then clinical events follow up for 3 years.

This description comes directly from the study's public registry record.

Talk to the study team

Chien-Boon Jong, MD  ·  035322140  ·  jgboon0407@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University Hospital Hsin-Chu branchHsinchu, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05672706